Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy

Developing effective therapies for the treatment of advanced head-and-neck squamous cell carcinoma (HNSCC) remains a major challenge, and there is a limited landscape of effective targeted therapies on the horizon. NAD(P)H:quinone oxidoreductase 1 (NQO1) is a 2-electron reductase that is overexpress...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neoplasia
Glavni autori: Lundberg, Alycen P., Boudreau, Matthew W., Selting, Kim A., Chatkewitz, Lindsay E., Samuelson, Jonathan, Francis, Joshua M., Parkinson, Elizabeth I., Barger, Anne M., Hergenrother, Paul J., Fan, Timothy M.
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2021
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274297/
https://ncbi.nlm.nih.gov/pubmed/34246985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2021.06.008
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items